Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT595 in chronic primary immune thrombocytopenia
NCT02859909Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Nov 2016
- Primary completion
- Dec 2018
- Countries
- 6
01
Overview
A Phase 3 trial of KIg10 in immune thrombocytopenia (ITP), sponsored by Biotest AG. Started Nov 2016; status: completed.
02
Drugs
KIg10
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02859909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859909.